- Acquired by Pincell srl, Jun 2025
- Went public, Jan 2008
- Raised $10M Undisclosed Round led by Yorkville Advisors Global, LP, Mar 2025
About
Scinai Immunotherapeutics Ltd. is an Israeli biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products. The company specializes in in-house development of inflammation and immunology biological therapeutic products, including a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs. Additionally, Scinai operates a boutique Contract Development and Manufacturing Organization (CDMO) providing services for drug development and GMP and non-GMP manufacturing for pre-clinical and clinical studies. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name in September 2023. Scinai's R&D unit focuses on inflammation and immunology (I&I) biological therapeutics, including anti-IL-17 NanoAb candidates for psoriasis and additional NanoAbs from collaborations with the Max Planck Society and University Medical Center Göttingen. The company also offers CDMO services, including biological drug development, analytical method development, process development, and clinical cGMP manufacturing services, with a focus on early-stage biotech clients in Israel, the United States, and Europe.
Funding history · 13 rounds · $37.6M total
Headcount over time
Q&A
- What is the current status of Scinai Immunotherapeutics?
- Scinai Immunotherapeutics was acquired by Pincell srl in June 2025.
- What was Scinai Immunotherapeutics' former name?
- Scinai Immunotherapeutics was formerly known as BiondVax Pharmaceuticals.
- Where is Scinai Immunotherapeutics headquartered?
- Scinai Immunotherapeutics is headquartered in Jerusalem, Israel, specifically at the Jerusalem BioPark, Hadassah Ein Kerem Campus.
- How many employees does Scinai Immunotherapeutics have?
- Scinai Immunotherapeutics has 11-50 employees.
- What is Scinai Immunotherapeutics' primary focus?
- Scinai Immunotherapeutics is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products, primarily for the treatment of autoimmune and infectious diseases.
- When was Scinai Immunotherapeutics founded?
- Scinai Immunotherapeutics was founded in July 2003.
- What was the most recent funding event for Scinai Immunotherapeutics?
- In October 2025, Scinai Immunotherapeutics received a grant of $246,000 from the Israel Innovation Authority.
- Who are the key executives at Scinai Immunotherapeutics?
- The key executives at Scinai Immunotherapeutics include Amir Reichman (CEO), Elad Mark (COO), and Tamar Ben-Yedidia, PhD (CSO).
- What is Scinai Immunotherapeutics' total raised capital?
- Scinai Immunotherapeutics has raised a total of $63,937,200 USD.
Team · 5
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | scinai.com/ |
|---|---|
| linkedin.com/company/725313 | |
| facebook.com/ScinaiSCNI | |
| YouTube | youtube.com/@Scinai |
| instagram.com/scinai.immunotherapeutics |
Identifiers & details
| Legal name | Scinai Immunotherapeutics Ltd. |
|---|---|
| Former names | BiondVax Pharmaceuticals |
| Founded | 2003-7 |
| Employees (exact) | 45 |
| Market cap | $2.3M |
| Status reason | Acquired by Pincell srl on Jun, 2025 |
Acquisitions & public offerings
Acquired by Pincell srl 2025-06
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| 2022-12 | $8.0M | |||
| 2021-12 | $9.8M | |||
| 2017-09 | $9.0M | |||
| 2015-05 | $9.5M | |||
| 2008-01 |
Radar intelligence
Web history (Wayback)
| Domain | scinai.com |
|---|
Certificate / subdomain footprint
| Subdomains | 4 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513436105 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה ציבורית |
| Incorporated | 2003-07-22 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2023 |
| Active charges / liens | 0 |
| Registry events | 2 — people (1), other (1) |
| Registered address | קרית הדסה בנין JBP 1 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-23 | עדכון דירקטורים-הסרת דירקטור |
| 2026-07-06 | שינוי סיווג חברה |